✦ LIBER ✦

Natriuretic peptide in heart failure: where we are, where we are going. Answer to the letter

✍ Scribed by Alberto Palazzuoli; Ranuccio Nuti

Book ID: 107481528
Publisher: Springer Milan
Year: 2011
Tongue: English
Weight: 92 KB
Volume: 6
Category: Article
ISSN: 1828-0447
DOI: 10.1007/s11739-011-0626-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natriuretic peptides in heart failure: w

Natriuretic peptides in heart failure: where we are, where we are going

✍ Alberto Palazzuoli; Giovanni Antonelli; Ilaria Quatrini; Ranuccio Nuti 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 161 KB

Natriuretic peptides in heart failure: w

Natriuretic peptides in heart failure: where we are, where we are going

✍ Michele Correale; Antonio Totaro; Carmen Greco; Natale Daniele Brunetti; Matteo 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 88 KB

Structure functions and the emc effect -

Structure functions and the emc effect -where are we now and where are we going to ?-

✍ S.J. Wimpenny 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 992 KB

Modeling the Fontan Circulation: Where W

Modeling the Fontan Circulation: Where We Are and Where We Need to Go

✍ C. G. DeGroff 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 213 KB

Financial reporting in the twentieth cen

Financial reporting in the twentieth century: Where have we been, and where are we going?

✍ Munter, Paul; Robinson, Thomas 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 3 views

As we approach the beginning of the twenty-first century, it's important to pause and evaluate where we've been. What has happened to standard setting over the past century? What direction are we going? And what can the past teach us about the future?

Immunosuppressive therapies in the manag

Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going

✍ Antonio M. Risitano 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB